These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27658797)

  • 1. Synthesis and pharmacological evaluation of conformationally constrained glutamic acid higher homologues.
    Tamborini L; Cullia G; Nielsen B; De Micheli C; Conti P; Pinto A
    Bioorg Med Chem; 2016 Nov; 24(22):5741-5747. PubMed ID: 27658797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of conformationally constrained glutamic acid homologues and investigation of their pharmacological profiles.
    Conti P; Pinto A; Tamborini L; Grazioso G; De Sarro G; Bräuner-Osborne H; Szabo G; Gábor Hársing L; De Micheli C
    ChemMedChem; 2007 Nov; 2(11):1639-47. PubMed ID: 17849399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-hydroxy-1,2,5-oxadiazol-3-yl moiety as bioisoster of the carboxy function. Synthesis, ionization constants, and molecular pharmacological characterization at ionotropic glutamate receptors of compounds related to glutamate and its homologues.
    Lolli ML; Giordano C; Pickering DS; Rolando B; Hansen KB; Foti A; Contreras-Sanz A; Amir A; Fruttero R; Gasco A; Nielsen B; Johansen TN
    J Med Chem; 2010 May; 53(10):4110-8. PubMed ID: 20408529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacological evaluation of novel conformationally constrained homologues of glutamic acid.
    Conti P; Caligiuri A; Pinto A; Roda G; Tamborini L; Nielsen B; Madsen U; Frydenvang K; Colombo A; De Micheli C
    Eur J Med Chem; 2007 Aug; 42(8):1059-68. PubMed ID: 17346858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, preliminary evaluation and molecular modeling studies of new, conformationally constrained analogues of the competitive NMDA receptor antagonist 4-(phosphonomethyl)-2-piperidinecarboxylic acid (CGS 19755).
    Pellicciari R; Marinozzi M; Natalini B; Costantino G; Lankin DC; Snyder JP; Monahan JB
    Farmaco; 1997; 52(6-7):477-86. PubMed ID: 9490080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids.
    Conti P; De Amici M; Joppolo Di Ventimiglia S; Stensbøl TB; Madsen U; Bräuner-Osborne H; Russo E; De Sarro G; Bruno G; De Micheli C
    J Med Chem; 2003 Jul; 46(14):3102-8. PubMed ID: 12825948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
    Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
    J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient synthesis of novel glutamate homologues and investigation of their affinity and selectivity profile at ionotropic glutamate receptors.
    Pinto A; Tamborini L; Mastronardi F; Ettari R; Romano D; Nielsen B; De Micheli C; Conti P
    Bioorg Med Chem Lett; 2014 Apr; 24(8):1980-2. PubMed ID: 24630559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of glutamic acid derivatives.
    Receveur JM; Guiramand J; Récasens M; Roumestant ML; Viallefont P; Martinez J
    Bioorg Med Chem Lett; 1998 Jan; 8(2):127-32. PubMed ID: 9871639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid.
    Feng B; Tse HW; Skifter DA; Morley R; Jane DE; Monaghan DT
    Br J Pharmacol; 2004 Feb; 141(3):508-16. PubMed ID: 14718249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties.
    Desos P; Lepagnol JM; Morain P; Lestage P; Cordi AA
    J Med Chem; 1996 Jan; 39(1):197-206. PubMed ID: 8568808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses, activity and modeling studies of 3- and 4-(sulfo- and sulfonamidoalkyl)pyridine and piperidine-2-carboxylic acid derivatives as analogs of NMDA receptor antagonists.
    el Hadri A; Maldivi P; Leclerc G; Rocher JP
    Bioorg Med Chem; 1995 Sep; 3(9):1183-201. PubMed ID: 8564410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
    Bettini E; Sava A; Griffante C; Carignani C; Buson A; Capelli AM; Negri M; Andreetta F; Senar-Sancho SA; Guiral L; Cardullo F
    J Pharmacol Exp Ther; 2010 Dec; 335(3):636-44. PubMed ID: 20810618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
    Luccini E; Musante V; Neri E; Raiteri M; Pittaluga A
    J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for understanding structure-activity relationships for the glutamate binding site of the NMDA receptor.
    Tikhonova IG; Baskin II; Palyulin VA; Zefirov NS; Bachurin SO
    J Med Chem; 2002 Aug; 45(18):3836-43. PubMed ID: 12190307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoenzymatic synthesis of new 2,4-syn-functionalized (S)-glutamate analogues and structure-activity relationship studies at ionotropic glutamate receptors and excitatory amino acid transporters.
    Assaf Z; Larsen AP; Venskutonytė R; Han L; Abrahamsen B; Nielsen B; Gajhede M; Kastrup JS; Jensen AA; Pickering DS; Frydenvang K; Gefflaut T; Bunch L
    J Med Chem; 2013 Feb; 56(4):1614-28. PubMed ID: 23414088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chiral synthesis and pharmacological evaluation of NPS 1407: a potent, stereoselective NMDA receptor antagonist.
    Moe ST; Smith DL; DelMar EG; Shimizu SM; Van Wagenen BC; Balandrin MF; Chien YE; Raszkiewicz JL; Artman LD; White HS; Mueller AL
    Bioorg Med Chem Lett; 2000 Nov; 10(21):2411-5. PubMed ID: 11078190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of two novel N-methyl-D-aspartate antagonists: EAA-090 (2-[8,9-dioxo-2,6-diazabicyclo [5.2.0]non-1(7)-en2-yl]ethylphosphonic acid) and EAB-318 (R-alpha-amino-5-chloro-1-(phosphonomethyl)-1H-benzimidazole-2-propanoic acid hydrochloride).
    Sun L; Chiu D; Kowal D; Simon R; Smeyne M; Zukin RS; Olney J; Baudy R; Lin S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):563-70. PubMed ID: 15075380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and pharmacological studies at the Gly/NMDA, AMPA and Kainate receptors of new oxazolo[4,5-c]quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring.
    Calabri FR; Colotta V; Catarzi D; Varano F; Lenzi O; Filacchioni G; Costagli C; Galli A
    Eur J Med Chem; 2005 Sep; 40(9):897-907. PubMed ID: 15919134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.
    Carling RW; Leeson PD; Moore KW; Moyes CR; Duncton M; Hudson ML; Baker R; Foster AC; Grimwood S; Kemp JA; Marshall GR; Tricklebank MD; Saywell KL
    J Med Chem; 1997 Feb; 40(5):754-65. PubMed ID: 9057862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.